Indication
Alopecia areata
Alopecia areata is a chronic, immune-mediated dermatologic disorder characterized by non-scarring hair loss that can affect any hair-bearing surface in children and adults. Read more about Alopecia areata
11 drugs 8 manufacturers
Drugs that treat it
Common Alopecia areata therapies.
TRIAMCINOLONE ACETONIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAlopecia areata is a chronic, immune-mediated dermatologic disorder characterized by non-scarring hair loss that can affect any hair-bearing surface in children and adults.
Pathophysiologically, it is driven by a breakdown of hair follicle immune privilege, leading to lymphocytic infiltration around anagen hair bulbs, follicular disruption, and premature transition into the telogen phase while sparing the follicular stem cells.
Clinically, it most often manifests as smooth, sharply demarcated, round or oval patches of sudden hair loss primarily on the scalp, accompanied by trichoscopic findings such as exclamation point hairs and occasional nail dystrophy.
Although the course is often relapsing and remitting, severe presentations may progress to the total loss of scalp hair or complete body hair loss.
- nih.gov
Alopecia areata is a chronic, immune-mediated dermatologic disorder characterized by non-scarring hair loss that can affect any hair-bearing surface in children and adults Clinically, it most often manifests as smooth, sharply demarcated, round or oval patches of sudden hair loss primarily on the scalp, accompanied by trichoscopic findings such as exclamation point hairs and occasional nail dystrophy
- nih.gov
Alopecia areata is a chronic, immune-mediated dermatologic disorder characterized by non-scarring hair loss that can affect any hair-bearing surface in children and adults Pathophysiologically, it is driven by a breakdown of hair follicle immune privilege, leading to lymphocytic infiltration around anagen hair bulbs, follicular disruption, and premature transition into the telogen phase while sparing the follicular stem cells Although the course is often relapsing and remitting, severe presentat...
- nih.gov
Pathophysiologically, it is driven by a breakdown of hair follicle immune privilege, leading to lymphocytic infiltration around anagen hair bulbs, follicular disruption, and premature transition into the telogen phase while sparing the follicular stem cells Clinically, it most often manifests as smooth, sharply demarcated, round or oval patches of sudden hair loss primarily on the scalp, accompanied by trichoscopic findings such as exclamation point hairs and occasional nail dystrophy
Personalize your experience
Follow Alopecia areata and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.